Eisai Co. Ltd.

05/10/2022 | Press release | Distributed by Public on 05/09/2022 17:33

EISAI COMPLETES ROLLING SUBMISSION TO THE U.S. FDA FOR BLA OF LECANEMAB FOR EARLY ALZHEIMER’S DISEASE UNDER THE ACCELERATED APPROVAL PATHWAY